Molecular Templates Announces Presentations at the American Society of Hematology (ASH) 2019 Annual Meeting

NEXT STORY
Aprea Therapeutics Presents Results From French Phase Ib/II Clinical Trial of APR-246 and Azacitidine (AZA) in Patients with TP53 Mutant Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) at the 2019 American Society of Hematology (ASH) Annual Meeting in Orlando
PREV STORY
Onconova Therapeutics Announces Data on Genomic Profiles of Higher Risk Myelodysplastic Syndromes Patients Refractory to Azacitidine Therapy Enrolled into the Pivotal INSPIRE Trial and Updated Oral Rigosertib Data Informing a Potential Adaptive Clinical Trial Design at the American Society of Hematology 2019 Annual Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Revive Therapeutics Included in AdvisorShares® Newly Launched Psychedelics ETF

author_avatar
NASDAQ Market News

electroCore Announces Distribution Agreement with Doctor’s Medical LLC to Expand Patient Access to gammaCore

author_avatar
NASDAQ Market News

NEOVACS PROVIDES CORPORATE UPDATE AND REPORTS FULL-YEAR 2017 FINANCIAL RESULTS

 PRESS RELEASE ·  PRESS RELEASE  · PRESS RELEASE NEOVACS PROVIDES CORPORATE UPDATE AND REPORTS ...

author_avatar
NASDAQ Market News